U.S. markets closed

Cumberland Pharmaceuticals Inc. (CPIX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.6750-0.0250 (-0.93%)
At close: 4:00PM EDT
Show:
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Breakdown
ttm
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Total Revenue
37,441
37,441
47,534
40,742
41,150
Cost of Revenue
8,653
8,653
8,752
7,378
7,371
Gross Profit
28,788
28,788
38,782
33,364
33,780
Operating Expense
35,170
35,170
42,405
40,754
37,861
Operating Income
-6,382
-6,382
-3,623
-7,391
-4,081
Net Non Operating Interest Income Expense
-188.282
-188.282
-2.822
368.636
206.422
Pretax Income
-6,570
-6,570
-3,626
-7,022
-3,875
Tax Provision
55.902
55.902
-79.316
16.636
4,175
Net Income Common Stockholders
-3,339
-3,339
-3,538
-6,963
-7,979
Diluted NI Available to Com Stockholders
-3,339
-3,339
-3,538
-6,963
-7,979
Basic EPS
-
-
-0.23
-0.45
-0.50
Diluted EPS
-
-
-0.23
-0.45
-0.50
Basic Average Shares
-
-
15,396
15,614
15,912
Diluted Average Shares
-
-
15,396
15,614
15,912
Total Operating Income as Reported
-6,382
-6,382
-3,623
-7,391
-4,081
Total Expenses
43,823
43,823
51,157
48,133
45,231
Net Income from Continuing & Discontinued Operation
-3,339
-3,339
-3,538
-6,963
-7,979
Normalized Income
-6,546
-6,546
-3,538
-6,963
-7,979
Interest Income
75.345
75.345
243.364
564.484
299.326
Interest Expense
263.627
263.627
246.186
195.848
92.904
Net Interest Income
-188.282
-188.282
-2.822
368.636
206.422
EBIT
-6,306
-6,306
-3,380
-6,826
-3,782
EBITDA
-1,558
-
-
-
-
Reconciled Cost of Revenue
8,339
8,339
8,482
7,165
7,159
Reconciled Depreciation
4,749
4,749
4,404
2,983
2,648
Net Income from Continuing Operation Net Minority Interest
-6,546
-6,546
-3,538
-6,963
-7,979
Normalized EBITDA
-1,558
-1,558
1,025
-3,844
-1,134
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0